Hereditary Testing Market to Grow with a CAGR of 7.79% through 2030

Increasing prevalence of genetic disorders and rising awareness and demand for personalized medicine are factors driving the Global Hereditary Testing Market in the forecast period 2026-2030.

According to TechSci Research report, “Hereditary Testing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Hereditary Testing Market stood at USD 6.54 Billion in 2024 and is anticipated to grow with a CAGR of 7.79% in the forecast period through 2030. The global hereditary testing market has witnessed remarkable growth in recent years, driven by a convergence of factors that are reshaping the healthcare industry. Hereditary testing, also known as genetic testing or DNA testing, involves the analysis of an individual's genetic material to identify genetic mutations, variations, and predispositions to various diseases. It has become an integral part of personalized medicine, aiding in early disease detection, risk assessment, and tailored treatment plans.

The growing awareness among healthcare professionals and the general public about the benefits of personalized medicine has been instrumental in driving the demand for hereditary testing. Personalized medicine tailors medical treatment to an individual's genetic makeup, enabling more effective and targeted interventions. Patients and healthcare providers are increasingly seeking genetic information to make informed decisions regarding disease prevention, diagnosis, and treatment. This surge in demand has fueled the growth of the hereditary testing market.

One of the primary drivers of the global hereditary testing market is the continuous advancements in genomic science and technology. Over the past few decades, there have been significant breakthroughs in DNA sequencing, which have made genetic testing more affordable, accessible, and informative. Next-generation sequencing (NGS) and CRISPR-Cas9 gene editing technologies have revolutionized the field, enabling researchers and healthcare providers to decipher the human genome with unprecedented accuracy and speed. As a result, the potential applications of hereditary testing have expanded, driving market growth.

The prevalence of genetic disorders, such as cystic fibrosis, Huntington's disease, and hereditary breast and ovarian cancer, has driven the need for hereditary testing. Genetic testing allows for early detection and risk assessment of these disorders, facilitating early intervention and management. Additionally, as our understanding of the genetic basis of various diseases continues to expand, more genetic markers and associations are being identified, further boosting the demand for hereditary testing.

Direct-to-consumer genetic testing has gained popularity in recent years, making hereditary testing more accessible to the general public. DTC testing allows individuals to order genetic tests online or through retail outlets without the need for a healthcare provider's prescription. This convenience factor has attracted a wide range of consumers interested in exploring their genetic heritage, ancestry, and health predispositions. The ease of access and affordability of DTC testing have significantly contributed to the market's growth.

Governments and regulatory bodies across the globe have played a crucial role in shaping the hereditary testing market. They have established guidelines and regulations to ensure the accuracy and reliability of genetic testing services. Additionally, the regulatory environment has fostered innovation and investment in the industry by providing a framework for quality control and data protection, further boosting market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Hereditary Testing Market.”

The Global Hereditary Testing Market is segmented into disease type, technology, regional distribution and company

Based on disease type, Hereditary cancer testing is emerging as the fastest-growing segment within the hereditary testing market, driven by increasing awareness of genetic risk factors and advances in genomic technologies. With cancers such as breast, ovarian, colorectal, and prostate often linked to inherited mutations—like BRCA1 and BRCA2—demand for early detection and preventive strategies is rising. The growing availability of cost-effective, next-generation sequencing (NGS) has made these tests more accessible, encouraging both patients and healthcare providers to integrate genetic screening into routine care. Public health initiatives, direct-to-consumer testing options, and increased insurance coverage have further fueled market expansion. Additionally, the emotional and economic benefits of early diagnosis and targeted treatment options are prompting more individuals with a family history of cancer to seek testing. As precision medicine continues to evolve, hereditary cancer testing is positioned at the forefront, offering critical insights that support risk assessment, personalized care plans, and improved patient outcomes.

Based on region, Europe segment is expected to grow during the forecast period European governments often implement policies that encourage the integration of genetic testing into healthcare practices. This includes reimbursement programs, insurance coverage, and initiatives to promote public awareness and understanding of hereditary testing. European healthcare institutions, research organizations, and biotech companies frequently collaborate on projects related to genetic testing. These partnerships facilitate knowledge sharing, resource pooling, and the development of cutting-edge testing methods.

Major companies operating in Global Hereditary Testing Market are:

• Myriad Genetics, Inc.
• Illumina, Inc.
• Natera, Inc.
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Quest Diagnostics Incorporated
• COOPERSURGICAL, INC.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• SOPHiA GENETICS

Download Free Sample Report

Customers can also request 10% free customization in this report.

“The global hereditary testing market is experiencing robust growth, driven by a combination of scientific advancements, rising awareness of personalized medicine, the prevalence of genetic disorders, direct-to-consumer testing options, regulatory support, and strategic collaborations. As technology continues to evolve and our understanding of genetics deepens, the hereditary testing market is poised for continued expansion, offering promising prospects for improving healthcare outcomes and enhancing the quality of life for individuals around the world.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Hereditary Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing), By Technology (Cytogenetic, Biochemical, Molecular Testing), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Hereditary Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Hereditary Testing Market.

Contact

TechSci Research LLC       

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: https://www.techsciresearch.com